Schrödinger Inc.’s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said ...

Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an ...

Hidradenitis suppurativa (HS) is a relatively common skin disease, affecting as many as one percent of people worldwide. But ...

Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its ...

During the trial, patients treated with Fabhalta experienced a significant reduction in proteinuria as early as two weeks.

Operator Good morning and good afternoon, and welcome to the Novartis Q3 2024 results release conference call and live ...

which allows drugmakers to get their generic medicines approved for one or several—but not all—approved indications of their brand-name counterparts. Novartis disagrees with the decision and ...

With their headquarters in next year’s Host City, it’s great to have Novartis, a global leader in healthcare, supporting the ...

Swiss drug major Novartis AG on Tuesday raised its core operating income and sales guidance for fiscal 2024 after reporting ...

Swiss drug major, on Tuesday revised up its annual sales guidance after it reported a surge in net profit for the ...

California VC firm Aditum Bio is reaching across the Pacific to hatch a brand-new biotech. Teaming up with China ... Jimenez ...

The European Broadcasting Union (EBU) is delighted to announce Novartis as an ‘Official Partner’ for the 69th Eurovision Song Contest when it’s hosted in their hometown in Basel, Switzerland, next May ...